The prevention of anthracycline cardiomyopathy

This publication has 66 references indexed in Scilit:

• Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease.
  Heart, 1993
• Detection of Early Anthracycline Cardiotoxicity by Monitoring the Peak Filling Rate
  American Journal of Clinical Oncology, 1993
• Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects
  Cancer, 1992
• Increasing therapeutic effect and reducing toxicity of doxorubicin by N-acyl dehydroalanines
  European Journal of Cancer and Clinical Oncology, 1989
• Amelioration of 4′-epidoxorubicin-induced cardiotoxicity by sodium cromoglycate
  European Journal of Cancer and Clinical Oncology, 1989
• Doxorubicin cardiotoxicity: Response of left ventricular ejection fraction to exercise and incidence of regional wall motion abnormalities
  The International Journal of Cardiovascular Imaging, 1988
• Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer
  New England Journal of Medicine, 1988
• Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy
  The American Journal of Medicine, 1987
• Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity
  American Heart Journal, 1983
• Doxorubicin cardiotoxicity in children
  The Journal of Pediatrics, 1980